Folkvardsen Dorte Bek, Thomsen Vibeke Ø, Rigouts Leen, Rasmussen Erik Michael, Bang Didi, Bernaerts Gertjan, Werngren Jim, Toro Juan Carlos, Hoffner Sven, Hillemann Doris, Svensson Erik
International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.
J Clin Microbiol. 2013 Dec;51(12):4220-2. doi: 10.1128/JCM.01602-13. Epub 2013 Sep 25.
Tuberculosis patients may harbor both drug-susceptible and -resistant bacteria, i.e., heteroresistance. We used mixtures of rifampin-resistant and -susceptible Mycobacterium tuberculosis strains to simulate heteroresistance in patient samples. Molecular tests can be used for earlier discovery of multidrug resistance (MDR), but the sensitivity to detect heteroresistance is unknown. Conventional phenotypic drug susceptibility testing was the most sensitive, whereas two line probe assays and sequencing were unable to detect the clinically important 1% resistant bacteria.
结核病患者可能同时携带药物敏感菌和耐药菌,即异质性耐药。我们使用耐利福平与对利福平敏感的结核分枝杆菌菌株混合物来模拟患者样本中的异质性耐药。分子检测可用于更早发现多重耐药(MDR),但检测异质性耐药的灵敏度尚不清楚。传统的表型药物敏感性检测最为敏感,而两种线性探针检测法和测序法均无法检测出临床上重要的1%耐药菌。